The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons
Abstract
Background: Since the majority of apolipoprotein E (apoE) existing in the cerebrospinal fluid is associated with high-density lipoprotein (HDL), one should focus on the role of the apoE-HDL complex rather than on that of free apoE in cholesterol metabolism in the central nervous system. However, the apoE-isoform-specific effect of apoE-HDL on cholesterol transport remains unclarified. Results: Here we show that apoE3-HDL induced a marked cholesterol release from neurons, while apoE4-HDL induced little. To elucidate the mechanism underlying this phenomenon, we used a complex of lipid emulsion (EM) with recombinant apoE3 or apoE4 (apoE-EM) at various apoE concentrations. When a small number of apoE molecules were associated with EM, apoE3- and apoE4-EM, induced a marked cholesterol release to a level similar to that induced by EM alone. However, when apoE at given concentrations was incubated with EM, apoE3-EM induced a marked cholesterol release, while apoE4-EM induced little. Under these conditions, a greater number of apoE4 molecules were associated with EM than apoE3 molecules. When an increasing number of apoE molecules were associated with EM, both apoE3-EM and apoE4-EM induced little cholesterol release. Preincubation with β-mercaptoethanol increased the number of apoE3 molecules associated with EM similar to that of apoE4 molecules, indicating that the presence (apoE3) or absence (apoE4) of intermolecular disulfide bond formation is responsible for the association of a greater number of apoE4 molecules to EM than apoE3 molecules. Conclusion: These results suggest that although apoE and a lipid particle are lipid acceptors, when apoE and a lipid particle form a complex, apoE on the particle surface inhibits the lipid particle-mediated cholesterol release from cells in an apoE-concentration-dependent manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ApoE4-lipoproteins are poorly lipidated compared to apoE3-lipoproteins.
“apoE4-lipoproteins are poorly lipidated compared to apoE3-lipoproteins.”
From Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation (2023) · cites this paper as [17]
The Results section on apoE-containing HDL reports that apoE4-HDL releases less cholesterol from neurons than apoE3-HDL, while the Discussion reports more apoE4 molecules per lipid particle. Neither finding establishes that apoE4-lipoproteins contain less lipid than apoE3-lipoproteins. A search for comparative lipid content or lipidation found no passage addressing that claim. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Michikawa, M., Fan, Q., Isobe, I., & Yanagisawa, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741008.x · Cited by 244 · cited 2×
“Lipid analysis The extraction of lipids and the subsequent determination of the amounts of cholesterol and phospholipids in the HDL fraction were carried out according to previously described methods [9].”
MethodSelf-citationFagan, A. M., Holtzman, D. M., Munson, G., Mathur, T., Schneider, D., Chang, L. K., Getz, G. S., Reardon, C. A., Lukens, J., Shah, J. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30001 · Cited by 222
Gong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203934200 · Cited by 214
Self-citationLipid Binding-induced Conformational Change in Human Apolipoprotein E
Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., Lund-Katz, S., & Phillips, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106337200 · Cited by 113
Flagged first, then by citations
Research works printed but not linked: 34
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993, 90: 1977-1981. 10.1073/pnas.90.5.1977. · DOI · Paper page
- Wollmer MA, Streffer JR, Lutjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A: ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging. 2003, 24: 421-426. 10.1016/S0197-4580(02)00094-5. · DOI
- Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R: Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry. 2002, 7: 899-902. 10.1038/sj.mp.4001109. · DOI
- Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lutjohann D, Ghebremedhin E, Hegi T, Pasch T, Traxler M, Bruhl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C: Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol. 2003, 60: 29-35. · DOI
- Roheim PS, Carey M, Forte T, Vega GL: Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA. 1979, 76: 4646-4649. 10.1073/pnas.76.9.4646. · DOI · Paper page
- Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH: Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem. 1987, 262: 14352-14360. · DOI · Paper page
- Krimbou L, Denis M, Haidar B, Carrier M, Marcil M, Genest J: Molecular interactions between apolipoprotein E and the ATP-binding cassette transporter A1 (ABCA1): Impact on ApoE lipidation. J Lipid Res. 2004, 45: 839-848. 10.1194/jlr.M300418-JLR200. · DOI · Paper page
- Ito J, Zhang L-Y, Asai M, Yokoyama S: Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J Neurochem. 1999, 72: 2362-2369. 10.1046/j.1471-4159.1999.0722362.x. · DOI
- Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y: Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem. 2004, 24: 25511-25516. 10.1074/jbc.M311256200. · DOI
- Tall AR, Small DM: Body cholesterol removal: role of plasma high-density lipoproteins. Adv Lipid Res. 1980, 17: 1-51. · DOI
- Roheim PS: Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport. Am J Cardiol. 1986, 57: 3C-10C. 10.1016/0002-9149(86)91020-9. · DOI
- Phillips MC, Johnson WJ, Rothblat GH: Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim Biophys Acta. 1987, 906: 223-276. · DOI
- Hara H, Yokoyama S: Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem. 1991, 266: 3080-3086. · DOI
- Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, Rothblat GH: Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 1995, 34: 7955-7965. 10.1021/bi00024a021. · DOI
- Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC: Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta. 1991, 1085: 273-298. · DOI
- Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC: Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res. 1992, 33: 1091-1097. · DOI
- Hara H, Yokoyama S: Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high- density lipoprotein pathway. Biochemistry. 1992, 31: 2040-2046. 10.1021/bi00122a021. · DOI
- Li Q, Komaba A, Yokoyama S: Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry. 1993, 32: 4597-603. 10.1021/bi00068a016. · DOI
- Li Q, Czarnecka H, Yokoyama S: Involvement of a cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta. 1995, 1259: 227-234. · DOI
- Okuhira K, Tsujita M, Yamauchi Y, Abe-Dohmae S, Kato K, Handa T, Yokoyama S: Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J Lipid Res. 2004, 45: 645-652. 10.1194/jlr.M300257-JLR200. · DOI
- Saito H, Dhanasekaran P, Baldwin F, Weisgraber KH, Phillips MC, Lund-Katz S: Effects of polymorphism on the lipid interaction of human apolipoprotein E. J Biol Chem. 2003, 278: 40723-40729. 10.1074/jbc.M304814200. · DOI · Paper page
- Heeren J, Grewal T, Laatsch A, Becker N, Rinninger F, Rye KA, Beisiegel U: Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem. 2004, 279: 55483-55492. 10.1074/jbc.M409324200. · DOI · Paper page
- Fan QW, Isobe I, Asou H, Yanagisawa K, Michikawa M: Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: a review. J Amer Assoc. 2001, 24: 1-10.
- Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW: CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001, 294: 1354-1357. 10.1126/science.294.5545.1354. · DOI · Paper page
- Koudinov AR, Koudinova NV: Essential role for cholesterol in synaptic plasticity and neuronal degeneration. Faseb J. 2001, 15: 1858-1860. · DOI
- Hayashi H, Campenot RB, Vance DE, Vance JE: Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem. 2004, 279: 14009-14015. 10.1074/jbc.M313828200. · DOI
- Weisgraber KH, Shinto LH: Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J Biol Chem. 1991, 266: 12029-12034. · DOI · Paper page
- Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA: Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem. 1994, 269: 22358-22365. · DOI · Paper page
- Dong LM, Weisgraber KH: Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 1996, 271: 19053-19057. 10.1074/jbc.271.32.19053. · DOI · Paper page
- Raffai RL, Dong LM, Farese RV, Weisgraber KH: Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proc Natl Acad Sci USA. 2001, 98: 11587-11591. 10.1073/pnas.201279298. · DOI
- Hamanaka H, Katoh-Fukui Y, Suzuki K, Kobayashi M, Suzuki R, Motegi Y, Nakahara Y, Takeshita A, Kawai M, Ishiguro K, Yokoyama M, Fujita SC: Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum Mol Genet. 2000, 9: 353-361. 10.1093/hmg/9.3.353. · DOI
- Michikawa M, Gong JS, Fan QW, Sawamura N, Yanagisawa K: A novel action of Alzheimer's amyloid β-protein (Aβ): oligomeric Aβ promotes lipid release. J Neurosci. 2001, 21: 7226-7235. · DOI
- Yamamoto M, Morita SY, Kumon M, Kawabe M, Nishitsuji K, Saito H, Vertut-Doi A, Nakano M, Handa T: Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions. Biochim Biophys Acta. 2003, 1632: 31-39. · DOI
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038/227680a0. · DOI · Paper page
Cited by
Sorted by citations
ApoE Lipidation as a therapeutic target in Alzheimer’s disease
Lanfranco, M. F., Ng, C. A., & Rebeck, G. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176336 · Cited by 189
Apolipoprotein E and cholesterol in aging and disease in the brain
de Chaves, E. P., Narayanaswami, V., Christoffersen, C., & Nielsen, L. B. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.505 · Cited by 164
Nakamura, T., Watanabe, A., Fujino, T., Hosono, T., & Michikawa, M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-35 · Cited by 124
Self-citationOkoro, E. U., Zhao, Y., Guo, Z., Zhou, L., Lin, X., & Yang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044430 · Cited by 25
Valencia-Olvera, A. C., Balu, D., Faulk, N., Amiridis, A., Wang, Y., Pham, C., Avila-Munoz, E., York, J. M., Thatcher, G. R. J., & LaDu, M. J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01375-3 · Cited by 22
Metadata
- Authors
- Gong, J.-S., Morita, S.-Y., Kobayashi, M., Handa, T., Fujita, S. C., Yanagisawa, K., & Michikawa, M.
- Venue
- Molecular Neurodegeneration
- Published
- 2007-05-15
- Volume
- 2
- Issue
- 1
- ISSN
- 1750-1326
- PMC
- PMC1876452
- Cited by
- 31
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review